# Pulmonary Hypertension and Imatinib

> **NCT01092897** · — · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 130 (estimated)

## Conditions studied

- PAH

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01092897
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2014-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01092897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01092897, "Pulmonary Hypertension and Imatinib". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01092897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*